# Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma

> **NCT04743999** · PHASE2 · TERMINATED · sponsor: **Henry Ford Health System** · enrollment: 9 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **OTHER:** Quality of life questionnaire

## Key facts

- **NCT ID:** NCT04743999
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-27
- **Primary completion:** 2023-06-27
- **Final completion:** 2023-06-27
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04743999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04743999, "Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04743999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*